ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2720

30-Day Hospital Readmission for Granulomatosis with Polyangiitis: Analysis from National Readmission Database

Yiming Luo1, Changchuan Jiang1, Ana Belen Arevalo Molina1, Shane Murray1, Maria Salgado2 and Jiehui Xu3, 1Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY, 3Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis – ANCA-Associated Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Granulomatosis with polyangiitis (GPA) is a systemic vasculitis with multi-organ involvement which can lead to frequent hospitalizations. Our study is to investigate characteristics and predictors of 30-day hospital readmission in GPA

Methods:

We used data from the National Readmission Database (NRD) for the year 2014. Diagnoses were identified by ICD-9 diagnosis code. Non-elective hospital admissions from January to November with a diagnosis of GPA (ICD-9 code 446.4) were included. Readmission was defined as hospital admissions within 30 days of discharge of a prior hospitalization. We studied characteristics of readmissions and non-readmissions. Mixed-effects multivariable logistic regression controlling for clustering of hospitals was performed to investigate the independent predictors for readmissions. To represent the national hospitalization data, analyses was accounted for the complex survey design and stratification of the data per NRD database sets.

Results:

A total of 9,119 hospital admissions with a diagnosis of GPA were identified in the year 2014. There were 2,173 readmissions within 30 days (23.8%). The top five primary diagnoses for readmissions were GPA (10.2%), sepsis (8.3%), pneumonia (5.8%), acute respiratory failure (2.6%) and acute kidney injury (AKI, 2.5%). Compared with non-readmissions, GAP readmissions were less likely to have private insurance (19% vs 26%, p < 0.001), more likely to have acute in-hospital events including acute respiratory failure (20% vs 18%, p = 0.021), sepsis (17% vs 15%, p = 0.009) and acute decompensated heart failure (10% vs 6%, p < 0.001), more likely to have chronic comorbidities including congestive heart failure (28% vs 20%, p < 0.001) and chronic kidney disease (62% vs 48%, p < 0.001), more likely to have higher hospital length of stay (8.0 vs 7.2 days, p = 0.019) and less likely to discharge home (50% vs 61%, p < 0.001) (Table 1). For GPA admissions, those who were readmitted within 30 days after discharge were more likely to be younger (OR = 0.99, p < 0.001), with higher Charlson Comorbidity Index (OR = 1.12, p = 0.044), have congestive heart failure (OR = 1.75, p = 0.001), develop AKI in the hospital (OR = 1.39, p = 0.006) and discharge to home health care (OR = 1.29, p = 0.041), and less likely to have private insurance (OR = 0.50, p < 0.001) (Table 2).

Conclusion:

There is a major burden of 30-day readmission among GPA patients. Predictors of readmissions include younger age, public insurance status, higher Charlson Comorbidity Index, heart and kidney complications and unfavorable discharge dispositions.

Table 1

Readmission

Not a readmission

P value

Demographic characteristics

Age

61

62

0.844

Gender (female)

51%

53%

0.113

Primary payer

Medicare

68%

62%

0.001

Medicaid

10%

8%

0.493

Private

19%

26%

< 0.001

Other

3%

4%

0.291

Median income of patient ZIP code, state quartiles

First (lowest)

23%

20%

0.112

Second

25%

27%

0.358

Third

26%

25%

0.52

Fourth

26%

28%

0.283

Clinical characteristics of hospitalizations

Charlson Comorbidity Index

2.67

2.25

< 0.001

Acute in-hospital events

Acute respiratory failure

20%

18%

0.021

Pneumonia

22%

24%

0.178

Sepsis

17%

15%

0.009

Acute myocardial infraction

2%

3%

0.208

Acute decompensated heart failure

10%

6%

< 0.001

Acute kidney injury

30%

28%

0.563

Chronic comorbidities

Hypertension

19%

25%

< 0.001

Diabetes mellitus

25%

23%

0.645

Coronary artery disease

23%

21%

0.132

Congestive heart failure

28%

20%

< 0.001

Obstructive lung disease*

32%

35%

0.479

Interstitial lung disease

5%

5%

0.606

Chronic kidney disease

62%

48%

< 0.001

Chronic liver disease

4%

3%

0.711

Cerebrovascular disease

6%

7%

0.55

Mortality

5%

6%

0.213

Length of stay

8.0

7.2

0.019

Hospital cost

19583

18478

0.289

Discharge disposition

Home

50%

61%

< 0.001

Home health care

22%

17%

< 0.001

Skilled nursing facility

20%

15%

< 0.001

Other

8%

7%

0.092

Hospital characteristics

Hospital location

Urban

99%

98%

0.342

Rural

1%

2%

Hospital teaching status

Teaching

71%

69%

0.286

Non-teaching

29%

31%

* Obstructive lung disease includes asthma, chronic obstructive pulmonary disease and bronchiectasis

Table 2

Adjusted odds ratio

P value

Demographic characteristics

Age

0.99

0.011

Gender (female)

1.01

0.947

Primary payer

Medicare

reference

Medicaid

0.95

0.810

Private

0.50

<0.001

Self-pay

0.59

0.207

No charge

0.70

0.565

Other

1.01

0.980

Median income of patient ZIP code, state quartiles

First (lowest)

reference

Second

0.81

0.163

Third

0.73

0.052

Fourth

0.79

0.158

Clinical characteristics of hospitalizations

Charlson Comorbidity Index

1.12

0.044

Acute in-hospital events

Acute respiratory failure

1.10

0.514

Pneumonia

0.86

0.243

Sepsis

0.94

0.665

Acute myocardial infraction

1.17

0.626

Acute decompensated heart failure

0.76

0.212

Acute kidney injury

1.39

0.006

Chronic comorbidities

Hypertension

1.21

0.192

Diabetes mellitus

0.99

0.954

Coronary artery disease

0.84

0.270

Congestive heart failure

1.75

0.001

Obstructive lung disease*

0.81

0.091

Interstitial lung disease

1.65

0.062

Chronic kidney disease

0.99

0.965

Chronic liver disease

1.12

0.629

Cerebrovascular disease

0.61

0.069

Discharge disposition

Home

reference

Home health care

1.29

0.041

Skilled nursing facility

1.03

0.852

Left against medical advice

1.63

0.317

Other

1.18

0.683

Hospital characteristics

Hospital location

Urban

reference

Rural

0.35

0.143

Hospital teaching status

Teaching

reference

Non-teaching

0.82

0.091

* Obstructive lung disease includes asthma, chronic obstructive pulmonary disease and bronchiectasis

 


Disclosure: Y. Luo, None; C. Jiang, None; A. B. Arevalo Molina, None; S. Murray, None; M. Salgado, None; J. Xu, None.

To cite this abstract in AMA style:

Luo Y, Jiang C, Arevalo Molina AB, Murray S, Salgado M, Xu J. 30-Day Hospital Readmission for Granulomatosis with Polyangiitis: Analysis from National Readmission Database [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/30-day-hospital-readmission-for-granulomatosis-with-polyangiitis-analysis-from-national-readmission-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/30-day-hospital-readmission-for-granulomatosis-with-polyangiitis-analysis-from-national-readmission-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology